How to store
a peptide properly.

Freeze-drying removes the water that a peptide needs to move. It does not remove the chemistry. Hydrolysis, deamidation, oxidation and aggregation all continue in the solid state, only much more slowly — and how much more slowly is decided by three variables a buyer can control, plus a fourth fixed long before the goods ship.^1,2

This is not a theoretical concern. Two vials from the same production lot, stored differently for eighteen months, can reach you with different purity, different colour and a different assay. Neither supplier did anything dishonest. One controlled moisture and the other did not.

Why a powder still degrades

Peptides fail through a short list of reactions: hydrolysis of the peptide bond, deamidation of asparagine and glutamine, oxidation of methionine, cysteine, tryptophan and histidine, and aggregation.¹ All of them require molecular mobility. In a dry solid, mobility is governed by how much water is left.

Water in a lyophilised cake does two jobs at once. It is a reactant in hydrolysis, and it is a plasticiser: it lowers the glass-transition temperature of the cake, softening the matrix until the other reactions can proceed.^2,3 Below a critical moisture content the cake behaves as a rigid glass and rates fall by orders of magnitude. Above it, the same chemistry resumes at a rate that is no longer negligible over a two-year shelf life.

So “keep it dry” is not folklore. It is the largest single lever on solid-state stability, and it is measurable by Karl Fischer titration before the vial ever leaves the factory.

Moisture is the variable that decides everything

For a lyophilised pharmaceutical, residual moisture is commonly specified at 3% w/w or below, and many protein formulations target 1% or lower.² A certificate that reads “≤ 5%” is wide enough to hide a material that will visibly cake within a year.

Residual water (w/w)	Cake behaviour	Practical outlook at −20 °C
≤ 1%	Rigid glass, no collapse	Multi-year
1–3%	Glass, slow chemistry	One to three years
3–6%	Softening, possible colour drift	Months to a year
> 6%	Caking, visible shrinkage	Weeks to months

The bands are indicative rather than a specification — the real limit depends on the peptide, the bulking agent and the counter-ion.³ What matters is the shape of the curve: very little happens, and then everything happens. There is no useful warning between 2% and 6%.

Moisture also enters after the factory. A lyophilised cake is hygroscopic, and an opened vial left on a bench in a humid room takes up water within minutes, not days. Every time the same vial is reopened, it starts from a wetter baseline. This is the mechanism behind most “it was fine when it arrived” complaints.

What temperature actually buys you

As a rule of thumb, reaction rates approximately double for every 10 °C — which is why the advice to “keep it cool” is directionally right and quantitatively useless without knowing the starting rate.⁵

For dry powder with low residual moisture, −20 °C is adequate for multi-year storage and 4 °C is acceptable for months. For long-term storage, 4 °C is the worst of the convenient options: warm enough for chemistry to proceed, cold enough that nobody worries about it.

Solutions are a different problem, and colder is not automatically better. When a solution freezes, solutes concentrate in the shrinking unfrozen channels between ice crystals. Local pH and ionic strength can shift far from the bulk values, and the ice–water interface is itself a surface that promotes aggregation.⁵ For some molecules that makes −20 °C worse than 4 °C over the same period.

Freeze–thaw adds to this, and the damage is cumulative rather than reversible. Five cycles do not average out; they stack. The practical rule is to aliquot before the first freeze and never return a thawed aliquot to the freezer.⁵

Light, oxygen and trace metals

The residues that oxidise are methionine, cysteine, tryptophan and histidine. The reaction is driven by light, by dissolved oxygen, and by trace transition metals — iron and copper at parts-per-million levels are enough to matter.^1,5

ICH Q1B exists because clear glass is not neutral packaging: it defines the photostability conditions a substance is tested under precisely so that light exposure becomes a known quantity rather than an accident of packaging.⁷ Amber glass, a foil pouch or an opaque carton all solve the same problem. A photosensitive peptide shipped in a clear vial with no secondary packaging is a handling decision you can see from the outside.

Nitrogen blanking and chelating agents address the other two drivers in a formulation; at bench scale, the equivalent is simply not leaving a reconstituted solution open to air for longer than the session.

Once it is in solution

pH dominates, and the effect is larger than most people expect. Asparagine deamidation is slowest in the mildly acidic range, near pH 5–6, and accelerates sharply as pH moves toward neutral and alkaline.⁴ Sequence matters as much as pH: an Asn-Gly pair is the fastest-deamidating motif there is, with predicted half-times measured in days at neutral pH and 37 °C, against years for the same residue at pH 5.⁴

Buffer choice is not neutral either. Phosphate catalyses deamidation through general acid–base mechanisms, so two solutions at identical pH can degrade at measurably different rates depending on which buffer holds them.⁴ This is one of the few places where a formulator's choice is testable rather than rhetorical.

Peptide bonds themselves hydrolyse fastest at pH extremes and at aspartyl–prolyl sequences, where the bond is unusually labile.¹ A short peptide with an Asp-Pro site will not behave like a generic “stable peptide” no matter how it is stored.

One consequence worth stating plainly: the pH a cake is frozen from is largely the pH it keeps. Residual buffer salts hold the local environment in the solid state, so a formulation decision made at the freeze-drying step follows the powder all the way to the bench.²

A working protocol

1. Store dry powder at −20 °C, in the original sealed vial, desiccated, protected from light. Label the date of first opening on the vial, not in a notebook.
2. Equilibrate to room temperature before opening. A cold vial opened in a warm room condenses water directly onto the cake. This step costs twenty minutes and prevents the most common contamination event in the whole workflow.
3. Weigh or reconstitute immediately after opening. Do not leave an open vial on the bench while you find a pipette.
4. Make working aliquots once, at −80 °C. Single-use volumes, thawed once, discarded after the session.
5. Weigh against net peptide content, not label weight. A 5 mg vial at 82% net content contains 4.1 mg of peptide; assuming otherwise makes every concentration 18% low.⁶
6. Record the storage condition you actually used. If a result ever looks wrong, this is the first thing you will want.

At bench scale, the practical enemy is the vial you keep reopening. Buying the smallest vial that covers a single experiment costs more per milligram and less per usable milligram, because the second half of a large vial is usually compromised by the time you reach it.

If you are writing the specification, three lines belong on the purchase order rather than in a brochure: residual moisture with a method (Karl Fischer) and a limit, the storage condition the retest period was established under, and a photostability statement if the material ships in clear glass. Behind those three sits a stability protocol — ICH Q1A(R2) defines the long-term and accelerated conditions that make a retest period defensible rather than asserted.⁶

We report residual moisture, counter-ion and net peptide content as separate lines on every specification, rather than folding them into a single purity figure — see BPC-157 or GHK-Cu, where copper content and water content are stated independently of peptide purity. If you need a storage condition or retest period written into a specification, ask before the order is released.

Questions we get asked

Can I keep peptides in the fridge at 4 °C?

For weeks, yes. For long-term storage of dry powder, 4 °C sits in the least useful band: warm enough for degradation chemistry to proceed and, in a domestic fridge, humid enough that a poorly sealed vial takes up water every time the door opens. Use −20 °C for powder and −80 °C for solutions held longer than a few days.

Is −20 °C or −80 °C better?

It depends on the state of the material, not on the number. Dry powder with low residual moisture is generally fine at −20 °C. Frozen solutions are where −80 °C earns its place, because freeze-concentration in the unfrozen channels can make −20 °C behave worse than 4 °C for some sequences.

My powder turned from white to off-white. Is it degraded?

Colour drift is a signal, not an assay. It is consistent with moisture uptake, oxidation of tryptophan or methionine, or metal contamination — all of which also cost you assay. The only way to know how much is to re-run purity and net content, and in practice the answer matters less than the cause: find out how the vial was stored.

Does a frost-free freezer work?

Poorly. Frost-free cycles periodically warm the compartment to melt ice, so the temperature of the contents swings rather than holds. For a material whose degradation rate doubles per 10 °C, that cycling does more damage than a stable −20 °C. A non-frost-free freezer, or a dedicated −80 °C unit, is the better choice.

References

1. Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals. Pharm Res. 1989;6(11):903–918. PubMed
2. Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14(8):969–975. PubMed
3. Chang LL, Pikal MJ. Mechanisms of protein stabilization in the solid state. J Pharm Sci. 2009;98(9):2886–2908. PubMed
4. Robinson NE, Robinson AB. Molecular clocks. Proc Natl Acad Sci USA. 2001;98(3):944–949. PubMed
5. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129–188. PubMed
6. International Council for Harmonisation. Q1A(R2) Stability Testing of New Drug Substances and Products. ICH Harmonised Guideline, 2003. ich.org
7. International Council for Harmonisation. Q1B Photostability Testing of New Drug Substances and Products. ICH Harmonised Guideline, 1996. ich.org

Links are to the publisher or issuing body. Where a stable article page could change, the link resolves to a search on the publisher's own index rather than a fixed identifier.